CARIBOU BIOSCIENCES INC. - COMMON STOCK

Caribou Biosciences Announces Appointment of David Johnson to its Board of Directors

11 май 2022 15:00:00 Источник Nasdaq GlobeNewswire

Caribou Biosciences Reports First Quarter 2022 Financial Results and Provides Business Updates

09 май 2022 15:05:01 Источник Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conference

03 май 2022 15:05:00 Источник Nasdaq GlobeNewswire

Caribou Biosciences to Share CB-010 Initial Clinical Data at the Upcoming European Hematology Association (EHA) 2022 Hybrid Congress

25 апр 2022 15:05:00 Источник Nasdaq GlobeNewswire

Caribou Biosciences Presents Positive Preclinical Data for Allogeneic Anti-BCMA CAR-T Cell Therapy Candidate CB-011 at the American Association for Cancer Research (AACR) Annual Meeting

08 апр 2022 12:07:17 Источник Nasdaq GlobeNewswire

Caribou Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

21 мар 2022 15:02:00 Источник Nasdaq GlobeNewswire

Caribou Biosciences to Present Preclinical Data on CB-011, an Immune-Cloaked Allogeneic Anti-BCMA CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting

08 мар 2022 19:19:17 Источник Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conferences

07 мар 2022 15:10:57 Источник Nasdaq GlobeNewswire

Caribou Biosciences to Present at the SVB Leerink 11th Annual Global Healthcare Conference

07 фев 2022 15:05:00 Источник Nasdaq GlobeNewswire

Caribou Biosciences Appoints Syed Rizvi, M.D., as Chief Medical Officer

18 янв 2022 07:00:02 Источник Nasdaq GlobeNewswire

Caribou Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference

04 янв 2022 15:05:00 Источник Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conferences

17 ноя 2021 15:05:00 Источник Nasdaq GlobeNewswire

Caribou Biosciences Provides Business Update and Reports Third Quarter 2021 Financial Results

09 ноя 2021 15:05:03 Источник Nasdaq GlobeNewswire

Caribou Biosciences Appoints Dara Richardson-Heron, M.D., to its Board of Directors and Ruhi Khan as Chief Business Officer

08 ноя 2021 08:00:00 Источник Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conferences

20 окт 2021 15:00:00 Источник Nasdaq GlobeNewswire

Caribou Biosciences Appoints Biotechnology Industry Veteran Ran Zheng to its Board of Directors

29 сен 2021 15:05:00 Источник Nasdaq GlobeNewswire

Caribou Biosciences to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference

27 сен 2021 15:05:00 Источник Nasdaq GlobeNewswire

Caribou Biosciences Announces Publication of Data Demonstrating High Specificity Genome Editing with its Proprietary chRDNA Technology

02 сен 2021 15:05:01 Источник Nasdaq GlobeNewswire

Caribou Biosciences to Participate in Citi’s 16Th Annual BioPharma Virtual Conference

01 сен 2021 07:00:02 Источник Nasdaq GlobeNewswire

Caribou Biosciences Appoints Nancy Whiting, Pharm.D., to its Board of Directors

25 авг 2021 15:00:00 Источник Nasdaq GlobeNewswire